AU6085500A - A lung cancer associated retrovirus, gene delivery vector and methods of use thereof - Google Patents

A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Info

Publication number
AU6085500A
AU6085500A AU60855/00A AU6085500A AU6085500A AU 6085500 A AU6085500 A AU 6085500A AU 60855/00 A AU60855/00 A AU 60855/00A AU 6085500 A AU6085500 A AU 6085500A AU 6085500 A AU6085500 A AU 6085500A
Authority
AU
Australia
Prior art keywords
methods
lung cancer
gene delivery
cancer associated
delivery vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60855/00A
Inventor
Hung Y. Fan
Massimo Palmarini
James M. Sharp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU6085500A publication Critical patent/AU6085500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU60855/00A 1999-07-08 2000-07-08 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof Abandoned AU6085500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14286899P 1999-07-08 1999-07-08
US60142868 1999-07-08
PCT/US2000/018856 WO2001004266A1 (en) 1999-07-08 2000-07-08 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Publications (1)

Publication Number Publication Date
AU6085500A true AU6085500A (en) 2001-01-30

Family

ID=22501614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60855/00A Abandoned AU6085500A (en) 1999-07-08 2000-07-08 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Country Status (3)

Country Link
AU (1) AU6085500A (en)
GB (1) GB2368846B (en)
WO (1) WO2001004266A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US7608449B2 (en) 2003-05-14 2009-10-27 The Regents Of The University Of California Methods and compositions related to high-titer pseudotyped retroviruses
JP6092514B2 (en) 2008-06-30 2017-03-08 トカジェン インコーポレーテッド 5-Fluorocytosine formulations and uses thereof
CN105624193B (en) 2008-09-26 2021-07-13 索元生物医药(美国)有限公司 Recombinant vector
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
EP2632491A4 (en) 2010-10-31 2014-10-01 Tocagen Inc Enhanced cancer treatment and monitoring using recombinant vectors
EP2909324B1 (en) * 2012-10-25 2020-02-26 Tocagen Inc. Retroviral vector with mini-promoter cassette
US9642921B2 (en) 2012-12-20 2017-05-09 Tocagen Inc. Cancer combination therapy and recombinant vectors
CA2943640A1 (en) 2014-03-26 2015-10-01 Tocagen Inc. A retroviral vector having immune-stimulating activity
EA201890640A1 (en) 2015-09-04 2018-09-28 Токаджен Инк. RECOMBINANT VECTORS CONTAINING PEPTIDE 2A
CN115433719B (en) * 2022-10-10 2024-10-18 吉林大学 Sheep-derived immortalized cell line for preparing various viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676455A1 (en) * 1991-05-17 1992-11-20 Inst Nat Sante Rech Med Retrovirus JSRV - Nucleic acid and proteins characteristic of this retrovirus - their applications in diagnosis and therapy
GB9425600D0 (en) * 1994-12-19 1995-02-15 Medical Res Council Targeting complexes and use thereof
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Also Published As

Publication number Publication date
WO2001004266A9 (en) 2002-09-12
GB2368846B (en) 2004-08-25
GB2368846A (en) 2002-05-15
WO2001004266A1 (en) 2001-01-18
GB0203028D0 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
AU3395900A (en) Human lung cancer associated gene sequences and polypeptides
AUPR894201A0 (en) Respiratory delivery for gene therapy and lentiviral delivery particle
AU1409801A (en) Powder inhaler
AU5266698A (en) Directional drug delivery stent
AU2466299A (en) A new human tumor-associated gene
AU2002246925A1 (en) Therapeutic delivery balloon
AU2001264559A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU3287699A (en) Ultrasound-mediated drug delivery
AU2001227858A1 (en) Delivery of cardiac constraint jacket
AU4139801A (en) Controlled delivery of antigens
WO2003002142A8 (en) Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes
AU3928300A (en) Genes associated with diseases of the kidney
AU6085500A (en) A lung cancer associated retrovirus, gene delivery vector and methods of use thereof
AU4717299A (en) Nasal delivery of sildenafil citrate
AU2637100A (en) Delivery system and methods for gene therapy
AU2001280576A1 (en) Tissue-specific self-inactivating gene therapy vector
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU4089899A (en) Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU4096100A (en) Pseudotyped retroviral vector for gene therapy of cancer
AU2732000A (en) Reverse gene therapy
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU1752601A (en) Dry powder inhaler
GB0025890D0 (en) Gene therapy
AU2669301A (en) Inhalation delivery apparatus and method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase